JeanMarie Guenot is a familiar face in modern pharmaceutical and biotechnology industry having occupied several leadership positions. In fact there is hardly any department in the industry where she cannot perform, from Pharmaceutical R&D to Corporate & Commercial Development, Project & Alliance Management, and Venture Capital. Guenot is an expert in building companies from the scratch and also rebuilding those at the point of collapse.
With such pedigree, no serious-minded company throws away the chance of having her as a staff. Amphivena Therapeutics, Inc. is thus fortunate to have a personality of this magnitude as its CEO and President. Amphivena Therapeutics is no push-over in the industry either. The company on takeda.com commenced operation July 2013 in San Francisco, California. Being a pre-clinical stage company, its mission centers on eradicating blood cancers by coming up with breakthrough therapies that take advantage of the human immune system in completely eliminating tumor cells from their root. This helps in restoring cellular balance essential for blood formation, functioning and circulation. According to guenotllc.com, the company is focus on restoring the flow of life so as to save lives under the threat of fatal illnesses.
Dr. JeanMarie Guenot understands the challenges facing companies in the industry having gone through same when she founder SKS Ocular. Aside setting up the company, she stayed put and managed it to great heights. SKS is a start-up ophthalmic firm that specializes on dry AMD, glaucoma, ocular inflammation, sustained release ocular drug delivery technologies, and therapeutics for macular degeneration. She once worked for Hoffmann-La Roche in Basel and Shanghai as a business adviser. While she was Vice President of Corporate & Business Development at PDL BioPharma, she oversaw mergers, commercial product portfolio and licensing among many other responsibilities.
JeanMarie Guenot obtained her PhD from the University of California, San Francisco and went ahead to bag her MBA from The Wharton School at the University of Pennsylvania. She is an authority when it comes to areas such as neurology, oncology, ophthalmic diseases, cardiovascular diseases and autoimmune diseases.
Find more information about Jeanmarie Guenot at https://www.linkedin.com/in/jeanmarie-guenot-4a140617